Global contract manufacturing organization, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital.
The over-the-counter (OTC) product is used to treat vaginal atrophy and dryness and is due to launch later this year. Following the successful transfer of the product’s manufacturing technology, Orion Contract Manufacturing, based in Espoo, Finland, will be responsible for the launch and ongoing supply of the product to multiple markets.
“Our versatility manufacturing and packaging expertise also mean that we can scale the formulation up to commercial production while meeting multiple market requirements,” Esa Nauska, head of Orion Contract Manufacturing, said. “We’re looking forward to what will hopefully be a long and mutually beneficial partnership with Peptonic Medical.”
Orion Contract Manufacturing, based in Finland, is part of the Orion Corporation and specializes in the manufacture of finished dosage forms, including hormonal gels and solutions, small volume parenterals, tablets, capsules, dry powder inhalers, creams, ointments, and liquid formulations for the global pharmaceutical market. Orion has FDA/EMA/JP/ANVISA compliant facilities in Finland.
Peptonic Medical is a Swedish development company whose goal is to offer treatments for women suffering from vaginal atrophy during and after menopause. VagiVital is hormone-free and will be commercialized for non-prescription use.
(Source: Orion Contract Manufacturing; Peptonic Medical)
